Improved cutaneous wound healing after intraperitoneal injection of alpha-melanocyte-stimulating hormone

Experimental Dermatology

Volumn 24, Issue 3, 2015, Pages 198-203

  de Souza, Kênia Soares ^a   Cantaruti, Thiago Anselmo ^a   Azevedo, Geraldo Magela ^a,b   Galdino, Daniel Antero de Almeida ^a   Rodrigues, Claudiney Melquíades ^a   Costa, Raquel Alves ^a,c   Vaz, Nelson Monteiro ^a   Carvalho, Cláudia Rocha ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Hospital Publico Regional de Betim   (Brazil)

^c Campus de Sete Lagoas   (Brazil)

Author keywords

Alpha melanocyte stimulating hormone and scarless healing; Inflammation; Scars; Wound healing

Indexed keywords

ALPHA INTERMEDIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; WOUND HEALING PROMOTING AGENT; COLLAGEN; HORMONE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL INFILTRATION; COLLAGEN FIBER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; EXTRACELLULAR MATRIX; FIBROBLAST; GRANULATION TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; SKIN INJURY; SKIN STRUCTURE; WOUND HEALING; YOUNG ADULT; ANIMAL; C57BL MOUSE; CICATRIX; CYTOLOGY; DRUG EFFECTS; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; MAST CELL; METABOLISM; SKIN; ULTRASTRUCTURE;

ALPHA-MSH; ANIMALS; CICATRIX; COLLAGEN; FIBROBLASTS; HORMONES; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; LEUKOCYTE COUNT; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; SKIN; SKIN PHYSIOLOGICAL PHENOMENA; WOUND HEALING;

EID: 84923608638     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12609     Document Type: Article

References (46)

1. Bayat A, McGrouther D A, Ferguson M W. BMJ 2003: 326: 88-92.
2. Desmouliere A, Redard M, Darby I et al. Am J Pathol 1995: 146: 56-66.
3. Longaker M T, Whitby D J, Adzick N S et al. J Pediatr Surg 1990: 25: 63-68; discussion 68-69.
4. Longaker M T, Whitby D J, Ferguson M W et al. J Pediatr Surg 1989: 24: 799-805.
5. Bielefeld K A, Amini-Nik S, Alman B A. Cell Mol Life Sci 2013: 70: 2059-2081.
6. Gurtner G C, Werner S, Barrandon Y et al. Nature 2008: 453: 314-321.
7. Ud-Din S, Volk S W, Bayat A. Exp Dermatol 2014: 23: 615-619.
8. Gawronska-Kozak B, Bogacki M, Rim J S et al. Wound Repair Regen 2006: 14: 265-276.
9. Mescher A L, Neff A W. Adv Biochem Eng Biotechnol 2005: 93: 39-66.
10. Cowin A J, Brosnan M P, Holmes T M et al. Dev Dyn 1998: 212: 385-393.
11. Rolfe K J, Grobbelaar A O. ISRN Dermatol 2012: 2012: 698034.
12. Namazi M R, Fallahzadeh M K, Schwartz R A. Int J Dermatol 2011: 50: 85-93.
13. van Zuijlen P P, Ruurda J J, van Veen H A et al. Burns 2003: 29: 423-431.
14. Whitby D J, Ferguson M W. Development 1991: 112: 651-668.
15. Luger T A. J Dermatol Sci 2002: 30: 87-93.
16. Scholzen T, Armstrong C A, Bunnett N W et al. Exp Dermatol 1998: 7: 81-96.
17. Hiltz M E, Lipton J M. Peptides 1990: 11: 979-982.
18. Riol-Blanco L, Ordovas-Montanes J, Perro M et al. Nature 2014: 510: 157-161.
19. Brod S A, Hood Z M. J Neuroimmunol 2008: 193: 106-112.
20. Jahovic N, Arbak S, Tekeli O et al. Peptides 2004: 25: 129-132.
21. Luger T A, Brzoska T, Scholzen T E et al. Ann N Y Acad Sci 2000: 917: 232-238.
22. Raap U, Brzoska T, Sohl S et al. J Immunol 2003: 171: 353-359.
23. Benjannet S, Rondeau N, Day R et al. Proc Natl Acad Sci U S A 1991: 88: 3564-3568.
24. Catania A, Lipton J M. Endocr Rev 1993: 14: 564-576.
25. Luger T A, Scholzen T, Grabbe S. J Investig Dermatol Symp Proc 1997: 2: 87-93.
26. Muffley L A, Zhu K Q, Engrav L H et al. J Histochem Cytochem 2011: 59: 278-288.
27. Catania A. J Leukoc Biol 2007: 81: 383-392.
28. Getting S J. Pharmacol Ther 2006: 111: 1-15.
29. Becher E, Mahnke K, Brzoska T et al. Ann N Y Acad Sci 1999: 885: 188-195.
30. Bohm M, Luger T A, Tobin D J et al. J Invest Dermatol 2006: 126: 1966-1975.
31. Getting S J, Christian H C, Lam C W et al. J Immunol 2003: 170: 3323-3330.
32. Luger T A, Brzoska T, Ann Rheum Dis 2007: 66 (Suppl 3): iii52-iii55.
33. Lipton J M, Catania A. Immunol Today 1997: 18: 140-145.
34. Patel H B, Montero-Melendez T, Greco K V et al. Front Immunol 2011: 2: 41.
35. Ceriani G, Macaluso A, Catania A et al. Neuroendocrinology 1994: 59: 138-143.
36. Macaluso A, McCoy D, Ceriani G et al. J Neurosci 1994: 14: 2377-2382.
37. Schreml S, Szeimies R M, Prantl L et al. J Am Acad Dermatol 2010: 63: 866-881.
38. Delgado R, Carlin A, Airaghi L et al. J Leukoc Biol 1998: 63: 740-745.
39. Lyson K, McCann S M. Neuroendocrinology 1993: 58: 191-195.
40. Kalden D H, Scholzen T, Brzoska T et al. Ann N Y Acad Sci 1999: 885: 254-261.
41. Nicolaou A, Estdale S E, Tsatmali M et al. FEBS Lett 2004: 570: 223-226.
42. Kokot A, Sindrilaru A, Schiller M et al. Arthritis Rheum 2009: 60: 592-603.
43. Brzoska T, Luger T A, Maaser C et al. Endocr Rev 2008: 29: 581-602.
44. Driskell R R, Lichtenberger B M, Hoste E et al. Nature 2013: 504: 277-281.
45. Bohm M, Raghunath M, Sunderkotter C et al. J Biol Chem 2004: 279: 6959-6966.
46. Leung A, Crombleholme T M, Keswani S G. Curr Opin Pediatr 2012: 24: 371-378.